JSPR Other: a positive outcome, +19.8%

On November 6, 2026, Jasper Therapeutics, Inc. reached its Other. The result was a positive outcome, and the stock moved +19.8% in the window around the event. It had already run -15.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.